BMY Nov 2025 35.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:36AM EDT. Market open.
Loading interactive chart…
- Simply Wall St.
Does Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
- Business Wire
Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
PRINCETON, N.J., May 23, 2024--Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
- Zacks
Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
The FDA assigns a new target action date of Dec 29, 2024, to Bristol Myers (BMY) BLA for subcutaneous nivolumab (nivolumab and hyaluronidase).
© 2024 Yahoo. All rights reserved.